UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-Q

QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended November 30, 2025

or

TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from ____________ to ____________

Commission File Number: 001-35992

Oracle Corporation

(Exact name of registrant as specified in its charter)

Delaware

54-2185193

(State or other jurisdiction of

incorporation or organization)

(I.R.S. Employer

Identification No.)

2300 Oracle Way

Austin, Texas

78741

(Address of principal executive offices)

(Zip Code)

(737) 867-1000

(Registrant s telephone number, including area code)

Securities registered pursuant to Section 12(b) of the Act:

Title of each class

Trading Symbol(s)

Name of each exchange on which registered

Common Stock, par value $0.01 per share

ORCL

New York Stock Exchange

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes No

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T ( 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes No

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See the definitions of large accelerated filer, accelerated filer, smaller reporting company and emerging growth company in Rule 12b-2 of the Exchange Act.

Large accelerated filer

Accelerated filer

Non-accelerated filer

Smaller reporting company

Emerging growth company

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes No

The number of shares of registrant s common stock outstanding as of December 5, 2025 was: 2,873,130,000.

Table of Contents

ORACLE CORPORATION

FORM 10-Q QUARTERLY REPORT

TABLE OF CONTENTS

Page

PART I.

FINANCIAL INFORMATION

Item 1.

Financial Statements (Unaudited)

Condensed Consolidated Balance Sheets as of November 30, 2025 and May 31, 2025

Condensed Consolidated Statements of Operations for the Three and Six Months Ended November 30, 2025 and 2024

Condensed Consolidated Statements of Comprehensive Income for the Three and Six Months Ended November 30, 2025 and 2024

Condensed Consolidated Statements of Stockholders Equity for the Three and Six Months Ended November 30, 2025 and 2024

Condensed Consolidated Statements of Cash Flows for the Six Months Ended November 30, 2025 and 2024

Notes to Condensed Consolidated Financial Statements

Item 2.

Management s Discussion and Analysis of Financial Condition and Results of Operations

20

Item 3.

Quantitative and Qualitative Disclosures About Market Risk

38

Item 4.

Controls and Procedures

38

PART II.

OTHER INFORMATION

39

Item 1.

Legal Proceedings

39

Item 1A.

Risk Factors

39

Item 2.

Unregistered Sales of Equity Securities and Use of Proceeds

39

Item 5.

Other Information

40

Item 6.

Exhibits

41

Signatures

43

Table of Contents

PART I. FINANCIAL INFORMATION

Item 1. Financial Statements (Unaudited)

ORACLE CORPORATION

CONDENSED CONSOLIDATED BALANCE SHEETS

As of November 30, 2025 and May 31, 2025

(Unaudited)

(in millions, except per share data)

November 30,

2025

May 31,

2025

ASSETS

Current assets:

Cash and cash equivalents

19,241

10,786

Marketable securities

525

417

Trade receivables, net of allowances for credit losses of $539 and $557 as of November 30, 2025 and May 31, 2025, respectively

9,440

8,558

Prepaid expenses and other current assets

5,160

4,818

Total current assets

34,366

24,579

Non-current assets:

Property, plant and equipment, net

67,875

43,522

Intangible assets, net

3,760

4,587

Goodwill

62,207

62,207

Deferred tax assets

11,531

11,877

Other non-current assets

25,245

21,589

Total non-current assets

170,618

143,782

Total assets

204,984

168,361

LIABILITIES AND STOCKHOLDERS EQUITY

Current liabilities:

Notes payable and other borrowings, current

8,091

7,271

Accounts payable

10,140

5,113

Accrued compensation and related benefits

1,947

2,243

Deferred revenues

9,940

9,387

Other current liabilities

7,677

8,629

Total current liabilities

37,795

32,643

Non-current liabilities:

Notes payable and other borrowings, non-current

99,984

85,297

Income taxes payable

10,885

10,269

Operating lease liabilities

16,311

11,536

Other non-current liabilities

9,552

7,647

Total non-current liabilities

136,732

114,749

Commitments and contingencies

Oracle Corporation stockholders equity:

Preferred stock, $0.01 par value authorized: 1.0 shares; outstanding: none

Common stock, $0.01 par value and additional paid in capital authorized: 11,000 shares; outstanding: 2,873 shares and 2,807 shares as of November 30, 2025 and May 31, 2025, respectively

40,577

37,107

Accumulated deficit

(9,355

(15,481

Accumulated other comprehensive loss

(1,271

(1,175

Total Oracle Corporation stockholders equity

29,951

20,451

Noncontrolling interests

506

518

Total stockholders equity

30,457

20,969

Total liabilities and stockholders equity

204,984

168,361

See notes to condensed consolidated financial statements.

Table of Contents

ORACLE CORPORATION

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

For the Three and Six Months Ended November 30, 2025 and 2024

(Unaudited)

Three Months Ended

November 30,

Six Months Ended

November 30,

(in millions, except per share data)

2025

2024

2025

2024

Revenues:

Cloud

7,977

5,937

15,162

11,559

Software

5,877

6,064

11,598

11,830

Hardware

776

728

1,446

1,383

Services

1,428

1,330

2,777

2,594

Total revenues

16,058

14,059

30,983

27,366

Operating expenses:

Cloud and software(1)

3,990

2,746

7,597

5,344

Hardware(1)

215

172

393

333

Services(1)

1,169

1,167

2,268

2,314

Sales and marketing(1)

2,149

2,190

4,211

4,226

Research and development

2,561

2,471

5,051

4,777

General and administrative

409

387

786

745

Amortization of intangible assets

407

591

826

1,215

Acquisition related and other

21

31

35

44

Restructuring

406

84

808

157

Total operating expenses

11,327

9,839

21,975

19,155

Operating income

4,731

4,220

9,008

8,211

Interest expense

(1,057

(866

(1,980

(1,708

Non-operating income, net

2,668

36

2,741

57

Income before income taxes

6,342

3,390

9,769

6,560

Provision for income taxes

207

239

707

480

Net income

6,135

3,151

9,062

6,080

Earnings per share:

Basic

2.14

1.13

3.19

2.19

Diluted

2.10

1.10

3.11

2.13

Weighted average common shares outstanding:

Basic

2,864

2,790

2,845

2,775

Diluted

2,922

2,869

2,916

2,860

(1)Exclusive of amortization of intangible assets, which is shown separately.

See notes to condensed consolidated financial statements.

Table of Contents

ORACLE CORPORATION

CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME

For the Three and Six Months Ended November 30, 2025 and 2024

(Unaudited)

Three Months Ended

November 30,

Six Months Ended

November 30,

(in millions)

2025

2024

2025

2024

Net income

6,135

3,151

9,062

6,080

Other comprehensive loss, net of tax:

Net foreign currency translation (losses) gains

(90

(217

(62

Net unrealized (losses) gains on cash flow hedges

(9

28

(33

(88

Other, net

(2

(2

(1

(2

Total other comprehensive loss, net

(101

(191

(96

(87

Comprehensive income

6,034

2,960

8,966

5,993

See notes to condensed consolidated financial statements.

Table of Contents

ORACLE CORPORATION

CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS EQUITY

For the Three and Six Months Ended November 30, 2025 and 2024

(Unaudited)

Three Months Ended

November 30,

Six Months Ended

November 30,

(in millions, except per share data)

2025

2024

2025

2024

Common stock and additional paid in capital

Balance, beginning of period

39,378

33,083

37,107

32,764

Common stock issued

138

128

1,308

307

Stock-based compensation

1,156

1,170

2,280

2,176

Repurchases of common stock

(11

(6

(24

Shares repurchased for tax withholdings upon vesting of restricted stock-based awards

(92

(47

(109

(898

Other, net

(3

(13

(3

(15

Balance, end of period

40,577

34,310

40,577

34,310

Accumulated deficit

Balance, beginning of period

(14,054

(20,939

(15,481

(22,628

Repurchases of common stock

(139

(87

(276

Cash dividends declared

(1,436

(1,118

(2,848

(2,221

Net income

6,135

3,151

9,062

6,080

Other, net

(1

Balance, end of period

(9,355

(19,045

(9,355

(19,045

Other stockholders equity, net

Balance, beginning of period

(658

(875

(657

(897

Other comprehensive loss, net

(101

(191

(96

(87

Other, net

(6

37

(12

(45

Balance, end of period

(765

(1,029

(765

(1,029

Total stockholders equity

30,457

14,236

30,457

14,236

Cash dividends declared per common share

0.50

0.40

1.00

0.80

See notes to condensed consolidated financial statements.

Table of Contents

ORACLE CORPORATION

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

For the Six Months Ended November 30, 2025 and 2024

(Unaudited)

Six Months Ended

November 30,

(in millions)

2025

2024

Cash flows from operating activities:

Net income

9,062

6,080

Adjustments to reconcile net income to net cash provided by operating activities:

Depreciation

3,055

1,712

Amortization of intangible assets

826

1,215

Deferred income taxes

332

(601

Stock-based compensation

2,280

2,176

Gains from investments and other, net

(2,227

298

Changes in operating assets and liabilities:

Increase in trade receivables, net

(900

(451

Decrease in prepaid expenses and other assets

1,285

676

Decrease in accounts payable and other liabilities

(1,366

(1,143

Decrease in income taxes payable

(2,608

(1,685

Increase in deferred revenues

467

454

Net cash provided by operating activities

10,206

8,731

Cash flows from investing activities:

Purchases of marketable securities and other investments

(634

(636

Proceeds from sales and maturities of marketable securities and other investments

4,737

356

Capital expenditures

(20,535

(6,273

Net cash used for investing activities

(16,432

(6,553

Cash flows from financing activities:

Payments for repurchases of common stock

(95

(300

Proceeds from issuances of common stock

1,308

307

Shares repurchased for tax withholdings upon vesting of restricted stock-based awards

(109

(898

Payments of dividends to stockholders

(2,848

(2,221

Proceeds from (repayments of) commercial paper and other short-term financing, net

886

(396

Proceeds from issuances of senior notes and term loan credit agreements, net of issuance costs

17,880

11,837

Repayments of senior notes, term loan credit agreements and other borrowings

(2,122

(9,700

Other financing activities, net

(203

(276

Net cash provided by (used for) financing activities

14,697

(1,647

Effect of exchange rate changes on cash and cash equivalents

(16

(44

Net increase in cash and cash equivalents

8,455

487

Cash and cash equivalents at beginning of period

10,786

10,454

Cash and cash equivalents at end of period

19,241

10,941

Non-cash investing activities:

Unpaid capital expenditures

6,849

2,086

See notes to condensed consolidated financial statements.

Table of Contents

ORACLE CORPORATION

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

November 30, 2025

(Unaudited)

1.BASIS OF PRESENTATION, RECENT ACCOUNTING PRONOUNCEMENTS AND OTHER

Basis of Presentation

We have prepared the condensed consolidated financial statements included herein pursuant to the rules and regulations of the United States (U.S.) Securities and Exchange Commission. Certain information and footnote disclosures normally included in financial statements prepared in accordance with U.S. generally accepted accounting principles (GAAP) have been condensed or omitted pursuant to such rules and regulations. However, we believe that the disclosures herein are adequate to ensure the information presented is not misleading. These unaudited condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements and the notes thereto included in our Annual Report on Form 10-K for the fiscal year ended May 31, 2025.

We believe that all necessary adjustments, which consisted only of normal recurring items, have been included in the accompanying financial statements to present fairly the results of the interim periods. The results of operations for the interim periods presented are not necessarily indicative of the operating results to be expected for any subsequent interim period or for the fiscal year ending May 31, 2026. We reclassed certain revenues and other related disclosures to conform to the current period s presentation for all periods presented in our condensed consolidated statements of operations. Such reclassifications did not affect total revenue, income from operations or net income.

There have been no changes to our significant accounting policies as disclosed in our Annual Report on Form 10-K for the fiscal year ended May 31, 2025 that had a significant impact on our condensed consolidated financial statements or notes thereto as of and for the six months ended November 30, 2025.

Cash, Cash Equivalents and Restricted Cash

Restricted cash that was included within cash and cash equivalents as presented within our condensed consolidated balance sheets as of November 30, 2025 and May 31, 2025 and our condensed consolidated statements of cash flows for the six months ended November 30, 2025 and 2024 was immaterial.

Remaining Performance Obligations from Contracts with Customers

Trade receivables, net of allowance for credit losses, and deferred revenues are reported net of related uncollected deferred revenues in our condensed consolidated balance sheets as of November 30, 2025 and May 31, 2025. The revenues recognized during the six months ended November 30, 2025 and 2024 that were included in the opening deferred revenues balances as of May 31, 2025 and 2024 were approximately $7.0 billion and $6.9 billion, respectively. Revenues recognized from performance obligations satisfied in prior periods and impairment losses recognized on our receivables were immaterial in each of the three and six months ended November 30, 2025 and 2024, respectively.

Remaining performance obligations were $523.3 billion as of November 30, 2025, of which we expect to recognize approximately 10% as revenues over the next twelve months, 30% over the subsequent month 13 to month 36, 35% over the subsequent month 37 to month 60 and the remainder thereafter. We have elected the optional exemption to not disclose the variable consideration for contracts in which the variable consideration expected to be received over the duration of the contract is allocated entirely to the wholly unsatisfied performance obligations. Refer to Note 1 of Notes to Consolidated Financial Statements included in our Annual Report on Form 10-K for the fiscal year ended May 31, 2025 for more information about our remaining performance obligations.

Table of Contents

ORACLE CORPORATION

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)

November 30, 2025

(Unaudited)

Sales of Financing Receivables

We offer certain of our customers the option to acquire certain of our products and services offerings through separate long-term payment contracts. We generally sell these contracts that we have financed for our customers on a non-recourse basis to financial institutions within 90 days of the contracts dates of execution. We record the transfers of amounts due from customers to financial institutions as sales of financing receivables because we are considered to have surrendered control of these financing receivables. Financing receivables sold to financial institutions were $307 million and $1.1 billion for the three and six months ended November 30, 2025, respectively, and $266 million and $861 million for the three and six months ended November 30, 2024, respectively.

Non-Marketable Investments

Our non-marketable debt investments and equity securities and related instruments totaled $416 million and $2.1 billion as of November 30, 2025 and May 31, 2025, respectively, and are included in other non-current assets in the accompanying condensed consolidated balance sheets and are subject to periodic credit losses and impairment reviews. Certain of these non-marketable equity securities and related instruments are adjusted for observable price changes from orderly transactions. The majority of the non-marketable debt and equity investments we held as of May 31, 2025 were with Ampere Computing Holdings LLC (Ampere), an equity method investee. On March 19, 2025, SoftBank Group Corp. announced that it entered into an agreement with Ampere and its equity holders to acquire all of the equity interests of Ampere (the Ampere Acquisition). On November 25, 2025, the Ampere Acquisition was consummated and we received cash proceeds of $4.3 billion in exchange for our equity, debt and call option interests in Ampere. We recorded $2.7 billion of realized gain, which is included in the non-operating income, net line item in our condensed consolidated statements of operations for the three and six months ended November 30, 2025. We have no remaining investment in Ampere as of November 30, 2025.

Acquisition Related and Other Expenses

Acquisition related and other expenses primarily consist of personnel-related costs for transitional and certain other employees, certain business combination adjustments, including adjustments after the measurement period has ended, and certain other operating items, net.

Three Months Ended

November 30,

Six Months Ended

November 30,

(in millions)

2025

2024

2025

2024

Transitional and other employee-related costs

Business combination adjustments, net

(1

(5

Other, net

20

31

29

46

Total acquisition related and other expenses

21

31

35

44

Non-Operating Income, net

Non-operating income, net consists primarily of interest income, net foreign currency exchange losses, the noncontrolling interests in the net profits of our majority-owned subsidiaries (primarily Oracle Financial Services Software Limited and Oracle Corporation Japan), net gains and losses related to marketable and non-marketable investments, including net gains and losses attributable to equity method investments (primarily Ampere) and net other income and expenses, including net gains and losses from our investment portfolio related to our deferred compensation plan, for which an equal and offsetting amount was recorded to our operating expenses during the same period, and non-service net periodic pension income and losses.

Table of Contents

ORACLE CORPORATION

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)

November 30, 2025

(Unaudited)

Three Months Ended

November 30,

Six Months Ended

November 30,

(in millions)

2025

2024

2025

2024

Interest income

192

149

295

283

Foreign currency losses, net

(28

(9

(59

(59

Noncontrolling interests in income

(46

(47

(93

(90

Gains (losses) from marketable and non-marketable investments, net

2,493

(108

2,441

(177

Other income, net

57

51

157

100

Total non-operating income, net

2,668

36

2,741

57

Recent Accounting Pronouncements

Income Taxes: In December 2023, the Financial Accounting Standards Board (FASB) issued Accounting Standards Update (ASU) 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures (ASU 2023-09), which enhances the disclosures required for income taxes in our annual consolidated financial statements. ASU 2023-09 is effective for us for our annual reporting for fiscal 2026 on a prospective basis. Both early adoption and retrospective application are permitted. We are currently evaluating the impact of our pending adoption of ASU 2023-09 on our consolidated financial statements.

Income Statement: In November 2024, the FASB issued ASU 2024-03, Income Statement Reporting Comprehensive Income Expense Disaggregation Disclosures (Subtopic 220-40): Disaggregation of Income Statement Expenses and also issued subsequent guidance clarifying the effective date of the initial guidance (collectively, Subtopic 220-40), which enhances the disclosures required for expense disaggregation in our annual and interim consolidated financial statements. This guidance is effective for us for our annual reporting for fiscal 2028 and for interim period reporting beginning in fiscal 2029 on a prospective basis. Both early adoption and retrospective application are permitted. We are currently evaluating the impact of our pending adoption of Subtopic 220-40 on our consolidated financial statements.

Software Development Costs: In September 2025, the FASB issued ASU 2025-06, Intangibles Goodwill and Other Internal-Use Software (Subtopic 350-40): Targeted Improvements to the Accounting for Internal-Use Software (ASU 2025-06), which clarifies and modernizes the accounting for internal-use software. ASU 2025-06 is effective for us in the first quarter of fiscal 2029, with early adoption permitted. The standard permits application of the guidance using a prospective, retrospective, or modified transition approach. We are currently evaluating the impact of our pending adoption of ASU 2025-06 on our consolidated financial statements.

2.FAIR VALUE MEASUREMENTS

We perform fair value measurements in accordance with FASB Accounting Standards Codification (ASC) 820, Fair Value Measurement (ASC 820). ASC 820 defines fair value as the price that would be received from selling an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. When determining the fair value measurements for assets and liabilities required to be recorded at their fair values, we consider the principal or most advantageous market in which we would transact and consider assumptions that market participants would use when pricing the assets or liabilities, such as inherent risk, transfer restrictions and risk of nonperformance.

Table of Contents

ORACLE CORPORATION

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)

November 30, 2025

(Unaudited)

ASC 820 establishes a fair value hierarchy that requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. An asset s or a liability s categorization within the fair value hierarchy is based upon the lowest level of input that is significant to the fair value measurement. ASC 820 establishes three levels of inputs that may be used to measure fair value:

Level 1: quoted prices in active markets for identical assets or liabilities;

Level 2: inputs other than Level 1 that are observable, either directly or indirectly, such as quoted prices in active markets for similar assets or liabilities, quoted prices for identical or similar assets or liabilities in markets that are not active, or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities; or

Level 3: unobservable inputs that are supported by little or no market activity and that are significant to the fair values of the assets or liabilities.

Assets and Liabilities Measured at Fair Value on a Recurring Basis

Our assets and liabilities measured at fair value on a recurring basis consisted of the following (Level 1 and Level 2 inputs are defined above):

November 30, 2025

May 31, 2025

Fair Value Measurements

Using Input Types

Fair Value Measurements

Using Input Types

(in millions)

Level 1

Level 2

Total

Level 1

Level 2

Total

Assets:

Money market funds

11,834

11,834

2,220

2,220

Time deposits and other

66

506

572

59

526

585

Derivative financial instruments

21

21

54

54

Total assets

11,900

527

12,427

2,279

580

2,859

Liabilities:

Derivative financial instruments

26

26

Our cash equivalents and marketable securities investments consist of money market funds, time deposits and marketable equity securities. Marketable securities as presented per our condensed consolidated balance sheets included debt securities with original maturities at the time of purchase greater than three months and the remainder of the debt securities were included in cash and cash equivalents. We classify our marketable debt securities as available-for-sale debt securities at the time of purchase and reevaluate such classification as of each balance sheet date. As of November 30, 2025 and May 31, 2025, all of our marketable debt securities investments mature within one year. Our valuation techniques used to measure the fair values of our instruments that were classified as Level 1 in the table above were derived from quoted market prices and active markets for these instruments that exist. Our valuation techniques used to measure the fair values of Level 2 instruments listed in the table above were derived from the following: non-binding market consensus prices that were corroborated by observable market data, quoted market prices for similar instruments, or pricing models, such as discounted cash flow techniques, with all significant inputs derived from or corroborated by observable market data including reference rate yield curves, among others.

Based on the trading prices of the $106.1 billion and $90.3 billion of senior notes and other long-term borrowings and the related fair value hedges, if any, that we had outstanding as of November 30, 2025 and May 31, 2025, respectively, the estimated fair values of the senior notes and other long-term borrowings and the related fair value hedges, if any, using Level 2 inputs at November 30, 2025 and May 31, 2025 were $95.8 billion and $81.3 billion, respectively.

Table of Contents

ORACLE CORPORATION

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)

November 30, 2025

(Unaudited)

3.NOTES PAYABLE AND OTHER BORROWINGS

Senior Notes

In September 2025, we issued $18.0 billion par value of fixed-rate senior notes comprising the following:

November 30, 2025

(Dollars in millions)

Amount

Effective

Interest

Rate

$3,000, 4.45%, due September 2030

3,000

4.55%

$3,000, 4.80%, due September 2032

3,000

4.87%

$4,000, 5.20%, due September 2035

4,000

5.25%

$2,500, 5.875%, due September 2045

2,500

5.91%

$3,500, 5.95%, due September 2055

3,500

6.05%

$2,000, 6.10%, due September 2065

2,000

6.17%

Total fixed-rate senior notes

18,000

Unamortized discount/issuance costs

(118

Total fixed-rate senior notes, net

17,882

We issued the senior notes for general corporate purposes, which may include capital expenditures, repayment of indebtedness, future investments or acquisitions and payment of cash dividends on or repurchases of our common stock. The interest is payable semi-annually. We may redeem some or all of the senior notes of each series prior to their maturity, subject to certain restrictions and the payment of an applicable make-whole premium in certain instances.

The senior notes rank pari passu with any other existing and future unsecured and unsubordinated indebtedness of Oracle. All existing and future indebtedness and liabilities of the subsidiaries of Oracle are or will be effectively senior to the senior notes. We were in compliance with all senior notes-related covenants as of November 30, 2025. The other terms and conditions of the senior notes are set forth in, and the foregoing description of the senior notes is qualified in its entirety by reference to, the Officers Certificate filed herewith as Exhibit 4.01 and incorporated by reference herein.